Drug Design | Novartis

Discovery

Visualizing molecular glues

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Drug DesignInnovationNovartis Institutes for BioMedical ResearchScientific Research
From Our Labs

Turning the power of nuclear technology into a medical force

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

CancerOncologyTargeted TherapyDrug DevelopmentDrug Design
From Our Labs

Tuning drugs to succeed on the cell’s surface

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Biomedical ResearchDigitalDrug DiscoveryNovartis Institutes for BioMedical ResearchPostdoc ProgramDrug Design
From Our Labs

Rediscovering the power of nature’s exquisite complexity

Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research

Drug DiscoveryGene SequencingNovartis Institutes for BioMedical ResearchClinical ResearchBiomedical JobsDrug Design
From Our Labs

Countering the genome reprogramming of cancer cells

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

Biomedical ResearchNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesDrug Design
From Our Labs

Bringing virtual reality to the lab

Novartis researchers want to use the technology to help them design new drugs.

DigitalEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchDrug DevelopmentDrug Design
Discovery

Leveraging the liver’s ability to heal scarred tissue

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Biomedical ResearchNovartis Institutes for BioMedical ResearchClinical ScienceDrug Design